| Literature DB >> 28327874 |
Kálmán Havasi1, Péter Domsik1, Anita Kalapos1, Jackie S McGhie2, Jolien W Roos-Hesselink2, Tamás Forster1, Attila Nemes1.
Abstract
Background: Three-dimensional (3D) echocardiography coupled with speckle-tracking echocardiographic (STE) capability is a novel methodology which has been demontrated to be useful for the assessment of left atrial (LA) volumes and functional properties. There is increased scientific interest on myocardial deformation analysis in adult patients with corrected tetralogy of Fallot (cTOF).Entities:
Mesh:
Year: 2017 PMID: 28327874 PMCID: PMC5344657 DOI: 10.5935/abc.20170004
Source DB: PubMed Journal: Arq Bras Cardiol ISSN: 0066-782X Impact factor: 2.000
Figure 1- Images from three-dimensional (3D) full-volume dataset showing left atrium (LA) in a patient with corrected tetralogy of Fallot is presented: (A) apical four-chamber view, (B) apical two-chamber view, (C3) short-axis view at basal, (C5) mid- and (C7) superior left atrial level. A 3D cast (D), volumetric data (E), time - global volume and time - segmental strain curves (F) of the LA are also presented. Dashed curve (F) represents LA volume changes during cardiac cycle with maximum (Vmax), minimum (Vmin) LA volumes and LA volume at atrial contraction (VpreA). White arrow represents peak strain, while dashed arrow represents strain at atrial contraction (F). LA: left atrium; LV: left ventricle.
Demographic and clinical data of patients with tetralogy of Fallot and that of controls
| cTOF patients | Controls | p value | |
|---|---|---|---|
| Age (years) | 37.9 ± 11.3 | 39.2 ± 10.6 | 0.70 |
| Male gender (%) | 8 (42) | 14 (61) | 0.35 |
| Hypertension (%) | 3 (16) | 0 (0) | 0.08 |
| Hypercholesterolemia (%) | 1 (5) | 0 (0) | 0.45 |
| Diabetes mellitus (%) | 0 (0) | 0 (0) | 1.00 |
| β-blockers (%) | 5 (26) | 0 (0) | 0.01 |
| ACE-inhibitors (%) | 3 (16) | 0 (0) | 0.08 |
| Diuretics (%) | 3 (16) | 0 (0) | 0.08 |
| LA diameter (mm) | 42.4 ± 6.8 | 33.2 ± 3.8 | <0.0001 |
| LV end-diastolic diameter (mm) | 54.6 ± 19.6 | 48.3 ± 6.9 | 0.16 |
| LV end-diastolic volume (ml) | 113.7 ± 31.7 | 102.2 ± 21.1 | 0.17 |
| LV end-systolic diameter (mm) | 32.7 ± 7.1 | 30.4 ± 4.1 | 0.20 |
| LV end-systolic volume (ml) | 43.8 ± 23.2 | 35.6 ± 10.6 | 0.14 |
| Interventricular septum (mm) | 9.9 ± 1.5 | 9.5 ± 2.0 | 0.46 |
| LV posterior wall (mm) | 9.8 ± 1.5 | 9.4 ± 2.3 | 0.55 |
| LV ejection fraction (%) | 62.7 ± 11.5 | 65.4 ± 6.5 | 0.34 |
ACE: angiotensin-converting enzyme; LA: left atrial; LV: left ventricular; cTOF: corrected tetralogy of Fallot.
Comparison of 3DSTE-derived volumes and volume-based functional properties between patients with corrected tetralogy of Fallot and controls
| Calculated volumes | Stroke volumes | Emptying fractions | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Vmax | Vmin | VpreA | TASV | PASV | AASV | TAEF | PAEF | AAEF | |
| cTOF patients | 53.3 ± 28.1 | 35.1 ± 24.4 | 42.7 ± 26.0 | 18.2 ± 7.4 | 10.6 ± 6.4 | 7.6 ± 4.4 | 37.1 ± 11.7 | 21.4 ± 11.6 | 20.1 ± 10.8 |
| Controls | 36.8 ± 6.6 | 18.2 ± 6.3 | 26.3 ± 8.1 | 18.6 ± 4.1 | 10.5 ± 4.6 | 8.1 ± 3.2 | 51.4 ± 11.4 | 29.5 ± 13.3 | 31.1 ± 9.1 |
| p value | 0.009 | 0.003 | 0.006 | 0.84 | 0.96 | 0.71 | 0.0003 | 0.04 | 0.0009 |
Vmax: maximum left atrial volume; Vmin: minimum left atrial volume; VpreA: left atrial volume before atrial contraction; TASV: total atrial stroke volume; TAEF: total atrial emptying fraction; AASV: active atrial stroke volume; AAEF: active atrial emptying fraction; PASV: passive atrial stroke volume; PAEF: passive atrial emptying fraction. cTOF: corrected tetralogy of Fallot.
Comparison of 3DSTE-derived peak strains and strains at atrial contraction between patients with tetralogy of Fallot and controls (global and mean segmental parameters)
| Radial | Circumferential | Longitudinal | Three-dimensional | Area | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Global | Mean segmental | Global | Mean segmental | Global | Mean segmental | Global | Mean segmental | Global | Mean segmental | |
| cTOF patients | -12.8 ± 9.5 | -17.0 ± 8.5 | 13.2 ± 9.2 | 18.3 ± 8.8 | 17.4 ± 8.3 | 19.7 ± 8.1 | -7.0 ± 6.3 | -11.5 ± 6.2 | 33.1 ± 14.2 | 38.9 ± 13.7 |
| Controls | -18.0 ± 9.9 | -21.7 ± 8.9 | 29.0 ± 13.4 | 34.2 ± 13.1 | 26.3 ± 7.7 | 29.6 ± 7.4 | -11.0 ± 8.2 | -15.1 ± 6.9 | 59.7 ± 22.0 | 67.9 ± 21.7 |
| p value | 0.10 | 0.09 | 0.0001 | 0.0001 | 0.0008 | 0.0002 | 0.09 | 0.09 | 0.0001 | <0.0001 |
| cTOF patients | -2.8 ± 4.6 | -6.5 ± 5.6 | 4.5 ± 5.0 | 7.3 ± 5.0 | 2.9 ± 4.6 | 4.7 ± 3.9 | -1.7 ± 6.4 | -4.7 ± 4.8 | 8.1 ± 9.7 | 12.4 ± 8.9 |
| Controls | -7.2 ± 7.9 | -8.2 ± 5.5 | 11.2 ± 10.4 | 13.9 ± 9.2 | 8.1 ± 8.8 | 9.0 ± 5.8 | -5.5 ± 5.1 | -6.4 ± 4.8 | 16.7 ± 16.1 | 20.3 ± 14.2 |
| p value | 0.03 | 0.33 | 0.01 | 0.008 | 0.03 | 0.10 | 0.04 | 0.24 | 0.04 | 0.04 |
cTOF: corrected tetralogy of Fallot.